IP Library Granted Patent US 9,439,864
Granted Patent B2
US 9,439,864 · App. 14/324,734 · Granted Sep 13, 2016

Solvent extraction from biodegradable microparticles

Inventor: Greg Bryden Sebring (Longmont, CO)
Assignee: ANTRIABIO, INC.
A61K9/1682A61K9/16A61K38/26A61K38/28A61K47/48215
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,439,864
App. No.
14/324,734
Granted
Sep 13, 2016
Kind
B2
Abstract

Embodiments may include a method for reducing a solvent concentration in a plurality of microparticles. The method may involve contacting a mixture including the plurality of microparticles and the solvent with water to form an aqueous suspension. A first portion of the solvent may dissolve into the water of the aqueous suspension to reduce the solvent concentration in the plurality of microparticles from a first solvent concentration in the mixture to a second solvent concentration in the aqueous suspension. The method may also include transferring the aqueous suspension to a concentration unit that may further reduce the solvent concentration from the second solvent concentration to a third solvent concentration. The method may further include transferring a microparticle concentrate with the third solvent concentration to a washing unit to form an amalgam of washed microparticles with a fourth solvent concentration. The method may also include drying the amalgam of washed microparticles.

Claims (40)

1. A method for reducing a solvent concentration in a plurality of microparticles, the method comprising:

contacting a mixture comprising the plurality of microparticles and the solvent with water to form an aqueous suspension, wherein a first portion of the solvent dissolves into the water of the aqueous suspension to reduce the solvent concentration in the plurality of microparticles from a first solvent concentration in the mixture to a second solvent concentration in the aqueous suspension;

transferring the aqueous suspension to a concentration unit that further reduces the solvent concentration in the plurality of microparticles from the second solvent concentration to a third solvent concentration by:

(i) introducing additional water to the aqueous suspension in the concentration unit; and

(ii) removing at least a portion of the water and at least a portion of the solvent from the aqueous suspension in the concentration unit, wherein the additional water is introduced at a slower rate than the water and the solvent are removed from the concentration unit to form a microparticle concentrate with the third solvent concentration;

transferring the microparticle concentrate to a washing unit, wherein the microparticle concentrate is contacted with a washing solution to form an amalgam of washed microparticles with a fourth solvent concentration; and

drying the amalgam of washed microparticles to form the plurality of microparticles with a reduced solvent concentration.

2. The method of claim 1 , wherein the microparticles comprise biodegradable microspheres that contain a medically active agent.

3. The method of claim 2 , wherein the biodegradable microspheres comprise poly(lactic-co-glycolic) acid.

4. The method of claim 2 , wherein the medically active agent comprises PEGylated insulin.

5. The method of claim 1 , wherein the solvent in the microparticles comprises a halogenated organic solvent.

6. The method of claim 5 , wherein the halogenated organic solvent comprises methylene chloride.

7. The method of claim 1 , wherein the first solvent concentration in the mixture is 10 to 20 wt. %, and the second solvent concentration in the suspension is 1 to 5 wt. %.

8. The method of claim 7 , wherein the first solvent concentration in the mixture is about 15 wt. %, and the second solvent concentration in the suspension is about 2 wt. %.

9. The method of claim 1 , wherein the forming of the aqueous suspension hardens the microparticles to reduce an amount of a medically active agent contained in the microparticles from dissolving into the water in the aqueous suspension.

10. The method of claim 1 , wherein the concentration unit comprises a cross-flow filtration unit that removes the water and the solvent from the concentration unit without removing the microparticles.

11. The method of claim 1 , wherein the third solvent concentration in the microparticle concentrate is about 0.5 wt. %.

12. The method of claim 2 , wherein the microparticle concentrate comprises about 1 vol. % or more of the microspheres.

13. The method of claim 1 , wherein the washing unit separates a first group of microparticles having a target diameter from a second group of microparticles having a size outside the target diameter.

14. The method of claim 13 , wherein the washing unit uses a stack of porous screens to separate the first group of microparticles from the second group of microparticles.

15. The method of claim 13 , wherein the first group of microparticles has a target diameter ranging from 25 μm to 63 μm.

16. The method of claim 1 , wherein the washing solution comprises an inorganic base.

17. The method of claim 16 , wherein the inorganic base comprises sodium bicarbonate.

18. The method of claim 17 , wherein the sodium bicarbonate has a concentration of 0.1 to 1 w/w %.

19. The method of claim 1 , wherein the fourth solvent concentration in the amalgam of washed microparticles is 0.03 wt. % or less.

20. A method of preparing a plurality of biodegradable microspheres with a medically active agent, wherein the biodegradable microspheres have a reduced level of a preparation solvent, the method comprising:

contacting a mixture comprising the plurality of biodegradable microspheres and the preparation solvent with water to form an aqueous suspension, wherein a first portion of the preparation solvent dissolves into the water of the aqueous suspension to reduce the solvent concentration in the plurality of biodegradable microspheres from a first solvent concentration in the mixture to a second solvent concentration in the aqueous suspension;

transferring the aqueous suspension to a concentration unit that further reduces the solvent concentration in the plurality of biodegradable microspheres from the second solvent concentration to a third solvent concentration by:

(i) introducing additional water to the aqueous suspension in the concentration unit; and

(ii) removing at least a portion of the water and at least a portion of the preparation solvent from the aqueous suspension in the concentration unit, wherein the additional water is introduced at a slower rate than the water and the solvent are removed from the concentration unit to form a biodegradable microsphere concentrate with the third solvent concentration;

transferring the biodegradable microsphere concentrate to a washing unit, wherein the biodegradable microsphere concentrate is contacted with a washing solution to form an amalgam of washed biodegradable microspheres with a fourth solvent concentration; and

drying the amalgam of washed biodegradable microspheres to form the plurality of biodegradable microspheres with a reduced solvent concentration.

21. The method of claim 20 , wherein the biodegradable microspheres comprise poly(lactic-co-glycolic) acid.

22. The method of claim 20 , wherein the medically active agent comprises PEGylated insulin.

23. The method of claim 20 , wherein the preparation solvent comprises methylene chloride.

24. The method of claim 20 , wherein:

the first solvent concentration is 10 to 20 wt. %;

the second solvent concentration is 1 to 5 wt. %;

the third solvent concentration is about 0.5 wt. %; and

the fourth solvent concentration is 0.03 wt. % or less.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jul 1, 2022
From: SLR INVESTMENT CORP
To: REZOLUTE, INC.
Reel/Frame 060419/0315 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 15, 2021
From: REZOLUTE, INC.
To: SLR INVESTMENT CORP., AS COLLATERAL AGENT
Reel/Frame 055949/0730 →
MERGER AND CHANGE OF NAME Recorded Mar 1, 2018
From: ANTRIABIO, INC.; REZOLUTE, INC.
To: REZOLUTE, INC.
Reel/Frame 045082/0718 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY'S ADDRESS PREVIOUSLY RECORDED AT REEL: 033279 FRAME: 0990. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST. Recorded Nov 24, 2015
From: SEBRING, GREG BRYDEN
To: ANTRIABIO, INC.
Reel/Frame 037157/0130 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2014
From: SEBRING, GREG BRYDEN
To: ANTRIABIO
Reel/Frame 033279/0990 →
Continuity (1)
Related Publication 20160000713A1 · Jan 7, 2016